Trials / Unknown
UnknownNCT05974228
Bioglass Wound Dressing in Treatment of Chronic Wound in Different Stage:a Randomized Controlled Trial
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 80 (estimated)
- Sponsor
- Peking University Third Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
The goal of this randomized control trial is to test the efficacy and safety of a bioglass wound dressing in patients with chronic wound in different stages. The main question it aims to answer are: * Whether the bioglass wound dressing have better efficacy and safety than blank control in treatment of chronic wound in necrosis stable stage? * Whether the bioglass wound dressing have better efficacy and safety than blank control in treatment of chronic wound in granulation growth stage? Participants will be assigned with a 1:1 ratio into intervention group and control group. Participants of intervention group will receive bioglass wound dressing in addition with clinical optimal treatment plan. Participants of control group will only receive clinical optimal treatment plan.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Bioactive glass wound dressing | Bioactive glass wound dressing is a dressing covered on the wound bed |
Timeline
- Start date
- 2023-08-01
- Primary completion
- 2024-05-31
- Completion
- 2025-04-30
- First posted
- 2023-08-03
- Last updated
- 2023-08-03
Source: ClinicalTrials.gov record NCT05974228. Inclusion in this directory is not an endorsement.